Dorie Sher

1.3k citations

29 papers · 1.0k indexed · h-index 14

Impact in

Genetics top 2%
- Mesenchymal stem cell research
Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 19
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 5
- Hematopoietic Stem Cell Transplantation 4
Genetics 11
- Chronic Lymphocytic Leukemia Research 5
- Hemoglobinopathies and Related Disorders 3

Co-authors: Wendy Stock Amelia Bartholomew Mary C. Nelson Robert Deans Nadim Mahmud Joseph D. Mosca Sheila Patil Theodore D. Chung
Journals: Blood (12 papers)Journal of Clinical Oncology (2 papers)Transplantation (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Philippines Israel

In The Last Decade

Dorie Sher

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Dorie Sher

Since Specialization

Citations

This map shows the geographic impact of Dorie Sher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorie Sher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorie Sher more than expected).

Fields of papers citing papers by Dorie Sher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorie Sher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorie Sher. The network helps show where Dorie Sher may publish in the future.

Co-authors

The 25 scholars most cited alongside Dorie Sher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dorie Sher Line = papers co-authored together Dorie Sher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis Blood Advances ·Chenyu Lin, Anand Patel, Dezheng Huo, Theodore Karrison, Koen van Besien, John E. Godwin, Dorie Sher, Howie Lawrence Weiner, Margaret Green, James L. Wade, Rebecca B. Klisovic, Maria R. Baer, Richard A. Larson, Wendy Stock, Olatoyosi Odenike	2024	1
2	Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype Leukemia & lymphoma ·Xavier Poiré, Barry Kurt Moser, Robert E. Gallagher, Kristina Laumann, Clara D. Bloomfield, Bayard L. Powell, Gregory Koval, Kabir Gulati, Nicholas Holowka, Richard A. Larson, Martin S. Tallman, Frederick R. Appelbaum, Dorie Sher, Cheryl L. Willman, Elisabeth Paietta, Wendy Stock	2013	38
3	Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909 Haematologica ·Hui Liu, Jeffrey L. Johnson, Greg Koval, Gregory Malnassy, Dorie Sher, Lauren E. Damon, Eric D. Hsi, Donna Bucci, Claudia Linker, Bruce D. Cheson, Wendy Stock	2011	59
4	Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) Breast Cancer Research and Treatment ·Marilyn L. Slovak, Victoria Bedell, Danika L. Lew, Kathy S. Albain, Georgiana K. Ellis, Robert B. Livingston, Silvana Martino, Edith A. Perez, Gabriel N. Hortobágyi, Dorie Sher, Wendy Stock	2009	12
5	Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102). Blood ·Wendy Stock, Ben L. Sanford, Gerard Lozanski, Ravi Vij, John C. Byrd, Bayard L. Powell, Meir Wetzler, Dorie Sher, Colin G. Edwards, Michael E. Kelly, Sue Richards, Crystal Sung, Greg Malnassy, Eva Hoke, Clara D. Bloomfield, Richard A. Larson	2009	51
6	Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products Leukemia & lymphoma ·Melinda K. Gordon, Dorie Sher, Theodore Karrison, Partow Kebriaei, Karen Chuang, Yanming Zhang, Diane McDonnell, Andrew Artz, Lucy A. Godley, Olatoyosi Odenike, Elizabeth Rich, Laura C. Michaelis, Michael J. Thirman, Amittha Wickrema, Koen van Besien, Richard A. Larson, Wendy Stock	2008	6
7	Histone Deacetylase Inhibitor Romidepsin Has Differential Activity in Core Binding Factor Acute Myeloid Leukemia Clinical Cancer Research ·Olatoyosi Odenike, Serhan Alkan, Dorie Sher, John E. Godwin, Dezheng Huo, Stephen J. Brandt, Margaret Green, Jingping Xie, Yanming Zhang, David H. Vesole, Patrick J. Stiff, James R. Wright, Richard A. Larson, Wendy Stock	2008	55
8	Phase II Trial of Low Dose, Subcutaneous Decitabine in Myelofibrosis Blood ·Olatoyosi Odenike, John E. Godwin, Koen van Besien, Dezheng Huo, Dorie Sher, Patrick W. Burke, Scott E. Smith, Margaret Green, Julia Melnick, James L. Wade, Eric P. Lester, Rebecca B. Klisovic, Maria R. Baer, Richard A. Larson, Wendy Stock	2008	28
9	Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples International Journal of Oncology ·Wendy Stock, Daohai Yu, T. Karrison, Dorie Sher, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield	2006	21
10	Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710. Blood ·Wendy Stock, Richard C. Harvey, Barry Kurt Moser, Dorie Sher, Esther Schachter-Tokarz, Matthew Myers, James L. Slack, Bayard L. Powell, Clara D. Bloomfield, Richard A. Larson, Martin S. Tallman, Frederick R. Appelbaum, James H. Feusner, Cheryl L. Willman, Robert E. Gallagher	2006	2
11	Daunorubicin Dose Intensification during Treatment of Adult Acute Lymphoblastic Leukemia (ALL): Final Results from Cancer and Leukemia Group B Study 19802. Blood ·Wendy Stock, Jeffrey Johnson, Daohai Yu, Diane Bennett, Dorie Sher, Richard M. Stone, Jonathan E. Kolitz, Bayard L. Powell, Meir Wetzler, James W. Vardiman, Clara D. Bloomfield, Richard A. Larson	2005	7
12	Incorporation of Alemtuzumab into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL) Is Feasible: A Phase I/II Study from the Cancer and Leukemia Group B (CALGB 10102). Blood ·Wendy Stock, Daohai Yu, Ben L. Sanford, Gerard Lozanski, Spero R. Cataland, Ravi Vij, John C. Byrd, Bayard L. Powell, Meir Wetzler, Maher Albitar, Dorie Sher, Colin G. Edwards, Eva Hoke, Clara D. Bloomfield, Richard A. Larson	2005	13
13	Eradication of Minimal Residual Disease during Treatment of Mantle Cell Lymphoma: CALGB 59909. Blood ·Dorie Sher, Jeffrey L. Johnson, Mariah Siddiqui, Michael A. Caligiuri, Lloyd E. Damon, George P. Canellos, Charles Linker, Bruce D. Cheson, Wendy Stock	2004	2
14	Brusatol-mediated induction of leukemic cell differentiation and G1 arrest is associated with down-regulation of c-myc Leukemia ·Eugenia Mata‐Greenwood, Muriel Cuendet, Dorie Sher, David M. Gustin, Wendy Stock, JM Pezzuto	2002	72
15	STEM CELL TRANSPLANTATION ELIMINATES ALLOANTIBODY IN A HIGHLY SENSITIZED PATIENT1 Transplantation ·Amelia Bartholomew, Dorie Sher, Steven D. Sosler, Wendy Stock, Velta A. Lazda, Mabel Koshy, Steve Devine, Koen van Besien	2001	14
16	Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion Experimental Hematology ·Steven M. Devine, Amelia Bartholomew, Nadim Mahmud, Mary C. Nelson, Sheila Patil, Wayne Hardy, Cord Sturgeon, Terry A. Hewett, Theodore D. Chung, Wendy Stock, Dorie Sher, Scott M. Weissman, Karen Ferrer, Joseph D. Mosca, Robert Deans, Annemarie Moseley, Ronald Hoffman	2001	336
17	Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease Bone Marrow Transplantation ·Koen van Besien, Amelia Bartholomew, Wendy Stock, David Peace, Steve Devine, Dorie Sher, Jeff Sosman, Y-H Chen, Matthew Koshy, Robert S. Hoffman	2000	77
18	The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. Blood ·Shahab Uddin, Eleanor N. Fish, Dorie Sher, Concetta Gardziola, Oscar R. Colamonici, Merrill J. Kellum, Paula M. Pitha, Morris F. White, Leonidas C. Platanias	1997	91
19	Modulation of Monocyte Functions by Muramyl Triptide Phosphatidylethanolamine in a Phase II Study in Patients With Metastatic Melanoma JNCI Journal of the National Cancer Institute ·L. Liebes, Craig M. Walsh, Abraham Chachoua, Ruth Oratz, D. Richards, Howard S. Höchster, Denise Peace, D. Marino, Sandra Alba, Dorie Sher, Ronald H. Blum, J Vilček	1992	27
20	Polystyrene substratum for bulk culture of anchorage dependent cells Cytotechnology ·A. Kadouri, Dorie Sher, N.G. Maroudas	1988	5

About Dorie Sher

Dorie Sher is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Cancer Research and Molecular Medicine, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Hemoglobinopathies and Related Disorders (3 papers). The work is most often cited by research in Genetics (463 citations), Hematology (326 citations), Oncology (298 citations), Immunology (198 citations) and Pathology and Forensic Medicine (113 citations). Dorie Sher has collaborated with scholars based in United States, Philippines and Israel. Frequent co-authors include Wendy Stock, Amelia Bartholomew, Mary C. Nelson, Robert Deans, Nadim Mahmud, Joseph D. Mosca, Sheila Patil, Theodore D. Chung, Terry A. Hewett and Karen Ferrer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Transplantation, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact